
Opinion|Videos|December 23, 2024
Episode 1: Advancing Patient Care in Non–Muscle-Invasive Bladder Cancer
Author(s)Max Kates, MD
A panelist discusses how identifying intermediate-risk patients, managing disease heterogeneity in non–muscle-invasive bladder cancer, and addressing long-term care needs present key challenges in patient care while highlighting recent treatment advances that offer promising solutions.
Advertisement
Episodes in this series

Now Playing
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS
2
Daniel George, MD, on the significance of the capivasertib approval for PTEN-deficient prostate cancer
3
EV plus pembro approval reframes first conversation in MIBC diagnosis
4
FDA approves enfortumab vedotin plus pembrolizumab for MIBC
5



















